13F-HR filed by Commodore Capital LP
Commodore Capital LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 39 holding rows worth $1,495,487,511.
- Accession
- 0001831942-24-000006
- Filer
- CIK 1831942
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 39 entries on the cover page, a total value of $1,495,487,511 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,495,487,511 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MERUS N V | N5749R100 | COM | 4,360,000 | $196,330,800 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 3,165,000 | $136,474,800 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 1,487,756 | $111,715,598 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 2,167,793 | $93,323,489 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 1,884,084 | $71,463,306 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 3,973,245 | $69,889,380 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 860,000 | $58,746,600 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 5,833,333 | $54,833,330 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,375,000 | $54,505,000 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 1,275,000 | $52,632,000 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 1,050,000 | $45,496,500 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 6,425,000 | $43,176,000 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,725,000 | $39,864,750 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 866,468 | $36,365,662 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 3,165,000 | $34,213,650 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,934,653 | $33,875,774 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 1,555,954 | $33,608,606 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,525,000 | $32,528,250 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 3,410,384 | $27,862,837 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 2,000,000 | $27,500,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 1,895,003 | $27,098,543 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V104 | COM | 21,052,631 | $25,052,631 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 750,990 | $24,264,487 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 912,189 | $22,658,775 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 1,250,000 | $21,187,500 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 290,000 | $19,270,500 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,100,000 | $18,766,000 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 2,300,000 | $14,674,000 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 1,250,000 | $11,800,000 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 200,000 | $10,180,000 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 657,333 | $9,294,689 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 1,575,000 | $8,316,000 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 318,851 | $7,588,654 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 169,533 | $7,256,012 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 500,000 | $5,200,000 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 295,020 | $4,342,694 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 1,374,320 | $3,229,652 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 183,174 | $831,610 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 92,687 | $69,432 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001831942-24-000006 | this filing | 2024-05-15 | acceptance time not in the bulk data set |